Evaxion Biotech A/S

EVAX | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.27

+$0.06 (+1.87%)

Sep 22, 2026, 2:27 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $20.28M

Enterprise Value $13.38M

Beta 0.27

Average Volume 146.88K

Shares Outstanding (Diluted) 417.01K

Shares Change YoY -62.27%

Institutional Ownership 78.80%

Exchange NASDAQ

ISIN US29970R3030

Price Performance

Price Change 1M -3.3%

Price Change 3M -5.3%

Price Change 6M -13.2%

Price Change YTD -31.9%

Price Change 1Y 5.3%

Price Change 3Y -91.6%

Price Change 5Y -99.3%

1M CAGR (ann.) 3.5%

1Y CAGR (ann.) 6.3%

5Y CAGR (ann.) -62.8%

All-Time CAGR -59.1%

Valuation

PE Ratio -0.52

Forward PE 84.28

PEG Ratio 0.00

Forward PEG 0.01

PS Ratio 2.71

Forward PS 3.30

PB Ratio 2.13

P/FCF Ratio N/A

P/Adj. FCF Ratio N/A

P/OCF Ratio N/A

EV/Sales 1.79

EV/EBIT -1.35

EV/EBITDA -1.35

EV/FCF N/A

Earnings Yield -193.2%

FCF Yield 0.0%

Adj. FCF Yield 0.0%

Financial Health

Net Cash $8.34M

Total Debt $7.1M

Cash & Short-Term Investments $14M

Total Assets $19.38M

Current Ratio 5.06

Quick Ratio 5.06

Debt / Equity Ratio 0.75

Debt / EBITDA -0.72

Debt / FCF N/A

OCF / Debt 0.00

Interest Coverage -11.89

Altman Z-Score -8.93

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 100.0%

Operating Profit Margin -116.0%

EBITDA Margin -132.5%

Net Profit Margin -115.5%

FCF Margin 0.0%

Adj. FCF Margin 0.0%

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -44.6%

Return on Equity -61.4%

Return on Invested Capital -46.7%

Return on Capital Employed -53.5%

Return on Tangible Assets -44.6%

Historical Growth (CAGR)

Revenue CAGR 3Y 98.9%

Revenue CAGR 5Y 83.0%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 53.2%

EPS CAGR 5Y 44.8%

EPS CAGR 10Y N/A

FCF CAGR 3Y 150.0%

FCF CAGR 5Y 70.2%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 4

EPS Growth Next 3Y 33.6%

Revenue Growth Next 3Y 77.1%

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$0.01

EPS Growth Est (next Q) -200.0%

Revenue Est (next Q) $300K

Revenue Growth Est (next Q) -96.0%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $11.67

Price Target Upside 263.6%

Cash Flow

Operating Cash Flow $0

Free Cash Flow $0

Adj. Free Cash Flow $0

FCF Per Share $0

OCF Per Share $0

OCF/S Ratio 0.0%

Income Statement

Revenue $7.49M

Gross Profit $7.49M

Operating Income $-8.69M

EBITDA $-9.93M

Net Income $-8.65M

EPS (Diluted) -$6.20

Revenue / Employee $162.87K

Profit / Employee $-188.1K

Employees 46